Gestodene

Specifications

60282-87-3CAS Number

262-145-8EC Number

(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-oneIUPAC Name

C21H26O2Chemical Formula

310.4 g/molMolecular Weight

GESTODENE; 60282-87-3; Gestoden; Gestodeno; SH B 331; Gestodenum; DTXSID6046478; SH-B-331; 1664P6E6MI; DTXCID4026478; 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregna-4,15-dien-20-yn-3-one; 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-; Pregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-18,19-dinor-, (17alpha)-; (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-6,12-dien-5-one; (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,12-dien-5-one; 17-alpha-ethinyl-13-ethyl-17 beta-hydroxy-4,15-gonadien-3-one; RefChem:639914; 13-ethyl-17-hydroxy-18,19-dinor-17 alpha-pregna-4,15-dien-20-yn-3-one; 262-145-8; Gestodenum [INN-Latin]; Gestodeno [INN-Spanish]; MFCD00867858; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one; 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-; Gestinol; (8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; Gestodene [USAN:INN:BAN]; CAS-60282-87-3; CCRIS 9189; HSDB 3594; EINECS 262-145-8; BRN 4237181; SHB 331;WL 70; UNII-1664P6E6MI; Gestodene CRS; NCGC00164611-01; Gestodene; 13-Ethyl-17-hydroxy-18,19-dinor-17a-pregna-4,15-dien-20-yn-3-one; Gestinol; SHB 331; WL 70; 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-; Gestodene (Standard); GESTODENE [INN]; GESTODENE [MI]; Gestodene (USAN/INN); GESTODENE [HSDB]; GESTODENE [USAN]; 17-alpha-Ethinyl-13-ethyl-17-beta-hydroxy-4,15-gonadien-3-one; GESTODENE [MART.]; GESTODENE [WHO-DD]; SCHEMBL37271; Gestodene - Bio-X trade mark; orb1308480; GESTODENE [EP IMPURITY]; CHEMBL1213583; GESTODENE [EP MONOGRAPH]; Gestodene, >=98% (HPLC); GTPL11246; HY-B0110R; SHB-331; SHT-546; CHEBI:135323; HY-B0110; Tox21_112232; AC-474; BDBM50247973; Gestodene for system suitability CRS; MSK011114; s1376; SH-546; AKOS024462671; Femodene (ethinylestradiol, gestodene); Tox21_112232_1; CCG-267584; CS-1862; DB06730; FG23660; MSK011114-100A; 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-; Millinette (ethinylestradiol, gestodene); NCGC00263565-01; NCGC00263565-05; AC-20038; AS-13029; BG164505; G0404; Gestodene Solution in Acetonitrile, 100ug/mL; D04316; SBI-0654203.0001; AB01274782-01; AB01274782_02; F462717; Q408289; BRD-K97197005-001-03-2; Gestodene, European Pharmacopoeia (EP) Reference Standard; 17alpha -Ethynyl-17beta-hydroxy-18-methyl-4,15-estradien-3-one; 17alpha-ethynyl-17beta-hydroxy-18-methyl-4,15-estradien-3-one; 17alpha-ethynyl-17beta-hydroxy-18-methyl-estra-4,15-dien-3-one; (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; (17alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; 13beta-Ethyl-17beta-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; (1R,3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-1-ethynyl-1-hydroxy-1,3a,3b,4,5,8,9,9a,9b,10,11,11a-dodecahydro-7H-cyclopenta[a]phenanthren-7-one; (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-oneSynonyms